Developer docs
API playgroundTry for free, no card

Search company profiles

Sambrinvest

Full company profile

uuid0003yfd

Namestring
Sambrinvest
Legal namestring
S.A. Sambrinvest
Websiteurl
sambrinvest.be
Company typeenum
Private
Founded yearint
1985
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCharleroi, Belgium
HQ citystring
Charleroi
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital funding, mezzanine financing, equity investments, SME growth capital, regional private equity
Product category
Regional Private Equity and Venture Capital
Revenue model1 record
1Investment Returns
TypeTransaction Fee
Description

Sambrinvest generates returns through equity investments, mezzanine financing, and venture capital stakes in SMEs across Charleroi Métropole. Returns are realized through capital gains, dividend income, and exit proceeds from portfolio companies.

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sambrinvest is a private investment company that provides adapted financing solutions — equity investments, mezzanine financing, and venture capital — to small and medium-sized enterprises in the Charleroi Métropole region of Wallonia, Belgium. It manages €250M across approximately 350 partner companies supporting 8,000 jobs, with strategic focus on four pillars: industry, materials, agri-food, and life sciences. Beyond financing, Sambrinvest develops real estate projects (A6K-E6K hub, Dockin, Aerospacelab Megafactory) to strengthen the regional economic ecosystem.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sambrinvest is a private financial partner for SMEs in Charleroi Métropole, Belgium, offering adapted financing solutions. As an investment company, Sambrinvest provides direct and indirect financing for company development, including support for productive investments, working capital needs, growth operations, and transmission operations. Beyond financing, Sambrinvest develops real estate projects and strengthens economic ecosystems. The company manages €250 million across approximately 350 partner companies supporting 8,000 jobs. Sambrinvest's strategic focus centers on four economic pillars: industry, materials, agri-food, and life sciences. Notable projects include the A6K-E6K technology and digital hub (60,000 m²), the Dockin office building (5,000 m²), and the Aerospacelab Megafactory. The company also supports portfolio companies across sectors including construction, automotive, retail, medtech, and digital services.

Product and service6 records
1Equity Investments
CategoryEquity Financing
Description

Direct equity stakes in small and medium-sized enterprises in Charleroi Métropole, providing growth capital in exchange for ownership participation. Targets SME founders, owners, and management teams seeking capital for productive investments and growth.

2Mezzanine Financing
CategoryMezzanine Financing
Description

Hybrid debt-equity financing instruments tailored to SMEs in Charleroi Métropole, bridging the gap between traditional bank debt and full equity investment. Designed for SMEs requiring flexible capital structures for expansion or transition.

3Venture Capital
CategoryVenture Capital
Description

Venture capital funding for innovative startups and growth-stage companies in priority sectors (industry, materials, agri-food, life sciences), including participation in seed and Series A rounds alongside co-investors. Targets founders and CEOs of biotech, medtech, digital, and technology startups.

4Growth Financing
CategoryGrowth Capital
Description

Financing solutions supporting SME growth operations, productive investments, and external growth (M&A) activities. Designed for SMEs in Charleroi Métropole seeking to scale operations or acquire other businesses.

5Succession / Business Transmission Financing
CategorySuccession Financing
Description

Financing solutions for business transmission and succession operations in Charleroi Métropole, supporting family businesses and SMEs through ownership transitions and generational handover.

6Working Capital Financing
CategoryWorking Capital Financing
Description

Financing solutions addressing working capital and fonds de roulement needs of SMEs in Charleroi Métropole, providing liquidity to support day-to-day operations and short-term obligations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sambrinvest collaborates with Igretec on the A6K-E6K project, a strategic initiative focused on supporting innovative companies and entrepreneurs in the Charleroi region. This partnership represents a core element of regional economic development efforts.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1LRM
TypeRegional player
Description

Limburg Regional Investment Company provides equity and financing to SMEs in the Limburg province, offering a similar regional PE/VC mandate but in a different Belgian geography.

TypeBroad incumbent
Description

France's public investment bank providing financing, guarantees, and equity to SMEs across all stages; broader national mandate but directly co-invests with Sambrinvest on life sciences rounds.

3PMV
TypeRegional player
Description

Flemish regional investment company providing venture and growth capital to SMEs and infrastructure projects in Flanders; comparable mandate but operates in a different Belgian region.

TypeBroad incumbent
Description

Listed Belgian investment company with PE and venture capital activities across Europe; comparable Belgian roots and life sciences exposure but operates at significantly larger scale and broader geography.

TypeRegional player
Description

Société d'investissement wallonne providing equity and quasi-equity to Walloon SMEs, comparable regional mandate in southern Belgium.

TypeDirect peer
Description

Belgian venture capital firm focused on life sciences investments; comparable thematic focus (life sciences) and frequently co-invests alongside Sambrinvest in rounds like NeuVasQ.

TypeDirect peer
Description

Belgium-based independent PE/VC manager with multi-fund platform including venture, growth, and cleantech; comparable multi-instrument Belgian SME focus.

TypeDirect peer
Description

Liège-based Belgian regional investment fund providing equity, mezzanine, and venture capital to SMEs and startups, with comparable multi-instrument offering and similar public-mission mandate within Wallonia.

9SRIW
TypeDirect peer
Description

Société Régionale d'Investissement de Wallonie is the Walloon regional investment company providing financing to SMEs, closely comparable in mandate, geography, and instrument mix.

TypeBroad incumbent
Description

Belgian federal investment holding managing state shareholdings and strategic investments; broader national mandate but comparable role in channeling public capital to Belgian enterprises.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment41 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sambrinvest

Regional Private Equity and Venture Capitalsambrinvest.be

Sambrinvest firmographics

Firmographics
Name
Sambrinvest
Legal name
S.A. Sambrinvest
Website
https://sambrinvest.be
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Sambrinvest is headquartered

Location

Headquarters

HQ city
Charleroi
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Sambrinvest business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Investment Returns: Sambrinvest generates returns through equity investments, mezzanine financing, and venture capital stakes in SMEs across Charleroi Métropole. Returns are realized through capital gains, dividend income, and exit proceeds from portfolio companies.

Distribution channels1 record

Marketing channels3 records

Sambrinvest product offering

Product offering

Core offering

Sambrinvest is a private investment company that provides adapted financing solutions — equity investments, mezzanine financing, and venture capital — to small and medium-sized enterprises in the Charleroi Métropole region of Wallonia, Belgium. It manages €250M across approximately 350 partner companies supporting 8,000 jobs, with strategic focus on four pillars: industry, materials, agri-food, and life sciences. Beyond financing, Sambrinvest develops real estate projects (A6K-E6K hub, Dockin, Aerospacelab Megafactory) to strengthen the regional economic ecosystem.

Product overview

Sambrinvest is a private financial partner for SMEs in Charleroi Métropole, Belgium, offering adapted financing solutions. As an investment company, Sambrinvest provides direct and indirect financing for company development, including support for productive investments, working capital needs, growth operations, and transmission operations. Beyond financing, Sambrinvest develops real estate projects and strengthens economic ecosystems. The company manages €250 million across approximately 350 partner companies supporting 8,000 jobs. Sambrinvest's strategic focus centers on four economic pillars: industry, materials, agri-food, and life sciences. Notable projects include the A6K-E6K technology and digital hub (60,000 m²), the Dockin office building (5,000 m²), and the Aerospacelab Megafactory. The company also supports portfolio companies across sectors including construction, automotive, retail, medtech, and digital services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Equity Investments Direct equity stakes in small and medium-sized enterprises in Charleroi Métropole, providing growth capital in exchange for ownership participation. Targets SME founders, owners, and management teams seeking capital for productive investments and growth.
  • Mezzanine Financing Hybrid debt-equity financing instruments tailored to SMEs in Charleroi Métropole, bridging the gap between traditional bank debt and full equity investment. Designed for SMEs requiring flexible capital structures for expansion or transition.
  • Venture Capital Venture capital funding for innovative startups and growth-stage companies in priority sectors (industry, materials, agri-food, life sciences), including participation in seed and Series A rounds alongside co-investors. Targets founders and CEOs of biotech, medtech, digital, and technology startups.
  • Growth Financing Financing solutions supporting SME growth operations, productive investments, and external growth (M&A) activities. Designed for SMEs in Charleroi Métropole seeking to scale operations or acquire other businesses.
  • Succession / Business Transmission Financing Financing solutions for business transmission and succession operations in Charleroi Métropole, supporting family businesses and SMEs through ownership transitions and generational handover.
  • Working Capital Financing Financing solutions addressing working capital and fonds de roulement needs of SMEs in Charleroi Métropole, providing liquidity to support day-to-day operations and short-term obligations.

Companies that use Sambrinvest

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Sambrinvest technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sambrinvest partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • IgreteccoreStrategic or Co-development PartnerSambrinvest collaborates with Igretec on the A6K-E6K project, a strategic initiative focused on supporting innovative companies and entrepreneurs in the Charleroi region. This partnership represents a core element of regional economic development efforts.

Scale indicators3 records

Recent moves10 records

Expansion highlights6 records

Sambrinvest competitors and assessment

Company assessment

Regional players

  • LRM: Limburg Regional Investment Company provides equity and financing to SMEs in the Limburg province, offering a similar regional PE/VC mandate but in a different Belgian geography.
  • PMV: Flemish regional investment company providing venture and growth capital to SMEs and infrastructure projects in Flanders; comparable mandate but operates in a different Belgian region.
  • Investsud: Société d'investissement wallonne providing equity and quasi-equity to Walloon SMEs, comparable regional mandate in southern Belgium.

Broad incumbents

  • Bpifrance: France's public investment bank providing financing, guarantees, and equity to SMEs across all stages; broader national mandate but directly co-invests with Sambrinvest on life sciences rounds.
  • Gimv: Listed Belgian investment company with PE and venture capital activities across Europe; comparable Belgian roots and life sciences exposure but operates at significantly larger scale and broader geography.
  • SFPI (Federal Holding and Investment Company): Belgian federal investment holding managing state shareholdings and strategic investments; broader national mandate but comparable role in channeling public capital to Belgian enterprises.

Direct peers

  • Newton Biocapital: Belgian venture capital firm focused on life sciences investments; comparable thematic focus (life sciences) and frequently co-invests alongside Sambrinvest in rounds like NeuVasQ.
  • Capricorn Partners: Belgium-based independent PE/VC manager with multi-fund platform including venture, growth, and cleantech; comparable multi-instrument Belgian SME focus.
  • Noshaq: Liège-based Belgian regional investment fund providing equity, mezzanine, and venture capital to SMEs and startups, with comparable multi-instrument offering and similar public-mission mandate within Wallonia.
  • SRIW: Société Régionale d'Investissement de Wallonie is the Walloon regional investment company providing financing to SMEs, closely comparable in mandate, geography, and instrument mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Sambrinvest social profiles

Digital presence

Sambrinvest financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sambrinvest leadership team

Management profile

Number of profiles

Profiles6 records

Sambrinvest subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Sambrinvest funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sambrinvest M&A and investment

M&A and investment

M&A

Investments41 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sambrinvest

What does Sambrinvest do?

Sambrinvest is a private investment company that provides adapted financing solutions — equity investments, mezzanine financing, and venture capital — to small and medium-sized enterprises in the Charleroi Métropole region of Wallonia, Belgium. It manages €250M across approximately 350 partner companies supporting 8,000 jobs, with strategic focus on four pillars: industry, materials, agri-food, and life sciences. Beyond financing, Sambrinvest develops real estate projects (A6K-E6K hub, Dockin, Aerospacelab Megafactory) to strengthen the regional economic ecosystem.

Is Sambrinvest a public or private company?

Sambrinvest is a private company. It is classified as unknown and is currently operating.

When was Sambrinvest founded?

Sambrinvest was founded in 1985. It employs 11 to 50 people.

Where is Sambrinvest based?

Sambrinvest is headquartered in Charleroi, Belgium, in the Europe region.

How does Sambrinvest make money?

One revenue line is on record: investment Returns.

Who are Sambrinvest's main competitors?

Regional players on record are LRM, PMV and Investsud. Broad incumbents are Bpifrance, Gimv and SFPI (Federal Holding and Investment Company). Direct peers are Newton Biocapital, Capricorn Partners, Noshaq and SRIW.

Does Sambrinvest have an API?

No public API is recorded for Sambrinvest.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmafiaBelgium’s Novadip Biosciences Raises €10.4M to Fund Pivotal Clinical Trial and Unlock EIB Loan TrancheNovadip Biosciences closed a €10.4 million convertible financing round led by New Science Ventures, bringing total convertible financing to €20 million since June 2025. The funds will support completion of a pivotal Phase 3 trial of NVD003 for congenital pseudarthrosis of the tibia and prepare for a US BLA. The company aims to obtain market authorization by 2028.European BiotechnologyBrenus adds €11M to colorectal cancer vaccine developmentBrenus Pharma raised an €11 million Series A extension to complete Phase 1 development of its colorectal cancer vaccine STC-1010. The funding brings the Series A to €33.2 million, with new investors including Sambrinvest and Omega Investment Corp. Proceeds will advance the next drug candidate.FinSMEsBrenus Pharma Raises €11M in Series A Extension FundingBrenus Pharma, a Lyon-based immuno-oncology platform developer, raised €11M in Series A extension funding from Angelor, UI Investissement, and others. The round brings total funding to €38M, which the company will use to expand operations and R&D efforts.BioSpaceBrenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A ExtensionBrenus Pharma announced an €11 million extension to its Series A round, bringing total capital raised to €38 million. The funding supports its lead clinical-stage in-vivo immunotherapy STC-1010 for MSS mCRC and welcomes new investors from Europe and Asia-Pacific.BioSpaceElkedonia strengthens Board of Directors with appointment of Pierre d’Epenoux as Independent ChairmanElkedonia appointed Pierre d'Epenoux as Independent Chairman, bringing his experience from leading ImCheck Therapeutics, acquired by Ipsen in 2025. The company advances its first-in-class ELK1-targeting program for treatment-resistant depression, with 332 million people worldwide affected. The appointment aims to strengthen governance and strategic positioning.Pulse 2.0Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation PlatformEnodia Therapeutics has raised €20.7 million in seed financing to advance its SEC61-based small-molecule protein degradation platform that targets disease-driving proteins at the point of synthesis. The round was co-led by Elaia, Pfizer Ventures, and Bpifrance, with participation from multiple investors including Wallonie Entreprendre, Argobio Studio, MACSF, The Institut Pasteur, InvestSud, Sambrinvest, and Mission BioCapital. The company plans to advance its lead program toward preclinical candidate selection over the next year, initially focusing on inflammatory and autoimmune diseases with additional opportunities in oncology and viral infections.PR NewswireEQT Life Sciences leads €54 Million Series A Financing of ATB TherapeuticsEQT Life Sciences led a €54 million Series A financing for ATB Therapeutics, co-led with MRL Ventures Fund. The funds will accelerate clinical development of oncology and immunology therapeutics from its ATBioFarm platform, and Mark Throsby was appointed Executive Chair.WebcapitalriesgoCaixa Capital Risc lidera una ronda de €27 millones en AbolerIS Pharma. Participan Bioventures, SFPIM, Wallonie Entreprendre, Sambrinvest, Sudinvest, Newton y TurenneCaixa Capital Risc led a €27.3 million Series A funding round for Belgian biopharmaceutical company AbolerIS Pharma, with participation from investors including Sound Bioventures and Turenne Capital. The funds will accelerate the clinical development of AbolerIS's novel monoclonal antibody targeting the CD45RC receptor for autoimmune diseases. This investment supports the company's goal to establish a new standard of care with fewer side effects than existing immunosuppressive therapies.FinSMEsPluriomics Raises €2.5M in Additional FundingPluriomics, a biotech company, raised €2.5M from SFPI-FPIM and SambrInvest. The funds will accelerate international growth, develop cardiac safety assays, and expand cardiovascular drug discovery capabilities. The company aims to deliver cardiac drug discovery solutions using its iPSC-derived cardiomyocyte technology.